123 related articles for article (PubMed ID: 29723451)
21. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance in patients with advanced prostate cancer undergoing intermittent or continuous androgen blockade.
Chen W; Yu ZX; Xie H; Deng ZX; Zhang FY; Chen SY; Weng ZL
Ai Zheng; 2009 Feb; 28(2):150-3. PubMed ID: 19550127
[TBL] [Abstract][Full Text] [Related]
23. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
24. Clinical efficacy of different androgen deprivation therapies for prostate cancer and evaluation based on dynamic-contrast enhanced magnetic resonance imaging.
Guo W; Li M
Acta Biochim Pol; 2024; 71():12473. PubMed ID: 38812492
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of factors associated with changes in the oral glucose tolerance test, regardless of the values of fasting glucose].
Lauria MW; Dias IN; Soares MM; Cordeiro GV; Barbosa VE; Ramos AV
Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):708-13. PubMed ID: 22231974
[TBL] [Abstract][Full Text] [Related]
26. Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis.
Laspa E; Christen A; Efstathiadou Z; Johnston DG; Godsland IF
Diabet Med; 2007 Nov; 24(11):1269-78. PubMed ID: 17894832
[TBL] [Abstract][Full Text] [Related]
27. Abnormal cation exchange in insulin-resistant patients with essential hypertension.
Taylor DR; Wing JR; Sonnekus MI; Toman M; Milne FJ
Cardiovasc J Afr; 2008; 19(2):67-71. PubMed ID: 18516349
[TBL] [Abstract][Full Text] [Related]
28. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
[TBL] [Abstract][Full Text] [Related]
29. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
30. The impact of years since menopause on the development of impaired glucose tolerance.
Wu SI; Chou P; Tsai ST
J Clin Epidemiol; 2001 Feb; 54(2):117-20. PubMed ID: 11166525
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.
Alexopoulou O; Bex M; Kamenicky P; Mvoula AB; Chanson P; Maiter D
Pituitary; 2014 Feb; 17(1):81-9. PubMed ID: 23446424
[TBL] [Abstract][Full Text] [Related]
32. Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women.
Larsson H; Ahrén B
Diabetes Care; 1996 Dec; 19(12):1399-403. PubMed ID: 8941471
[TBL] [Abstract][Full Text] [Related]
33. [Incidence of impaired glucose tolerance in hospitalized essential hypertension patients without diabetes mellitus history and with normal fasting glucose].
Ren JY; Yu ZQ; Zhao D; Sun JY
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):134-7. PubMed ID: 19719989
[TBL] [Abstract][Full Text] [Related]
34. The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer.
Salonen AJ; Taari K; Ala-Opas M; Viitanen J; Lundstedt S; Tammela TL;
J Urol; 2012 Jun; 187(6):2074-81. PubMed ID: 22498230
[TBL] [Abstract][Full Text] [Related]
35. Glucose intolerance during hormonal therapy for prostate cancer.
Suzuki K; Nukui A; Hara Y; Morita T
Prostate Cancer Prostatic Dis; 2007; 10(4):384-7. PubMed ID: 17486109
[TBL] [Abstract][Full Text] [Related]
36. Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots.
Abrahamsson PA
Asian J Urol; 2017 Oct; 4(4):208-222. PubMed ID: 29387553
[TBL] [Abstract][Full Text] [Related]
37. A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy.
DeJongh J; Ahsman M; Snelder N
J Pharmacokinet Pharmacodyn; 2021 Aug; 48(4):465-477. PubMed ID: 33538922
[TBL] [Abstract][Full Text] [Related]
38. Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year.
Farrer M; Fulcher G; Albers CJ; Neil HA; Adams PC; Alberti KG
Metabolism; 1995 Aug; 44(8):1016-27. PubMed ID: 7637643
[TBL] [Abstract][Full Text] [Related]
39. International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries.
Liede A; Hallett DC; Hope K; Graham A; Arellano J; Shahinian VB
ESMO Open; 2016; 1(2):e000040. PubMed ID: 27843596
[TBL] [Abstract][Full Text] [Related]
40. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
